We are grateful to our colleagues for their interest and thoughtful comments on our Seminar about systemic lupus erythematosus (SLE).1 We appreciate the remarks from Qihe Xu, and Thomas Pabst and ...

We investigate how candidate pathogenic bacteria in gut communities affect the immune system and potentially affect autoimmune disease activity.

The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...

After the unexpected success of their PHOENYCS GO study for dapirolizumab pegol in lupus earlier this fall, Biogen and UCB ...

Halsey shared a health update on her mother Nicole Frangipane, who recently underwent a second surgery after being diagnosed ...

The 2021 approval by regulatory agencies of belimumab, a B lymphocyte stimulator (BLyS) inhibitor, and the 2022 approval of anifrolumab, a type I interferon inhibitor, has increased the therapeutic ...

Experts have called for greater awareness of lupus to promote better access to healthcare for those living with the condition ...

The glucose-lowering and weight-reducing drug class appears to benefit the heart and kidneys in people with lupus and lupus nephritis, independently of glucose-lowering and weight loss.